FIELD: medicine, pharmacy. SUBSTANCE: invention relates to synergistic compositions of 1-[2-(hydroxymethyl)-1,3-oxathiolane-5-yl]-5-fluorocytosine or its derivatives and 3'-azido-3'-deoxythymidine or its derivatives. Antiviral components of composition can be used at lower doses. Compositions are used in medicinal therapy, in part, for treatment or prophylaxis of HIV-infection. EFFECT: enhanced effectiveness of composition. 7 cl, 1 tbl
Authors
Dates
1998-05-20—Published
1992-03-05—Filed